CareDx, Inc.: Business Overview, Financials & Competitive Analysis
CareDx is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. The company is ...
Cyborg Score thesis
CareDx is a market-leading transplant diagnostics company expanding into specialty oncology with improving profitability guidance...
Read the full analyst-debate transcript →Get the Latest CareDx, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeCareDx, Inc. Overview
Pro stress-test →CareDx is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. The company is the leading provider of genomics-based information for transplant patients, with commercially available testing services including AlloSure Kidney, AlloMap Heart, AlloSure Heart, and AlloSure Lung for transplant monitoring.
Strategic Profile
Pro stress-test →CareDx generates the majority of revenue from testing services, and as of June 2026 had trailing 12-month revenue of $458M. In April 2026, CareDx entered a definitive agreement to divest its Lab Products business to EuroBio Scientific for $170 million, enabling focus on high-margin transplant diagnostics and expansion into oncology and cell therapy applications.
Competitive Landscape
Pro stress-test →CareDx is the leading provider of genomics-based information for transplant patients. The transplant diagnostics market includes niche genomics and molecular testing competitors. Veracyte is a VC-backed competitor in this space. CareDx differentiates through proprietary donor-derived cell-free DNA (dd-cfDNA) assays and integrated digital workflows for transplant centers, with expansion into specialty oncology providing additional competitive moats.
Industry Context
CareDx, Inc. operates in In-Vitro Diagnostics.
Key facts
Founded: 1998 · Headquarters: Brisbane, California, US · Revenue: $458M (trailing 12-month as of Q2 2026); 2026 full-year guidance: $490–$500M